VRCA
Verrica Pharmaceuticals Inc.
NASDAQ · Healthcare · Biotechnology · US
$4.45
−4.30%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 2.51x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 17.75x
- Price / sales
- 2.52x
- Price / cash flow
- -5.73x
Enterprise value
- Enterprise value
- $67.1M
- EV / sales
- 2.21x
- EV / EBITDA
- -2.50x
- EV / EBIT
- -2.38x
- Market cap
- $76.4M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026